New Zealand markets closed

Abbott Laboratories (ABT)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
110.22+1.57 (+1.45%)
At close: 04:03PM EDT
110.40 +0.18 (+0.16%)
After hours: 06:53PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 187.30B
Enterprise value 196.23B
Trailing P/E 24.82
Forward P/E 22.17
PEG ratio (5-yr expected) 6.50
Price/sales (ttm)4.29
Price/book (mrq)5.29
Enterprise value/revenue 4.41
Enterprise value/EBITDA 15.09

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-7.24%
S&P500 52-week change 3-11.93%
52-week high 3142.60
52-week low 3101.24
50-day moving average 3111.86
200-day moving average 3121.92

Share statistics

Avg vol (3-month) 35.47M
Avg vol (10-day) 36.23M
Shares outstanding 51.75B
Implied shares outstanding 6N/A
Float 81.74B
% held by insiders 10.74%
% held by institutions 175.42%
Shares short (14 Jun 2022) 414.02M
Short ratio (14 Jun 2022) 42.69
Short % of float (14 Jun 2022) 40.82%
Short % of shares outstanding (14 Jun 2022) 40.80%
Shares short (prior month 12 May 2022) 413.57M

Dividends & splits

Forward annual dividend rate 41.88
Forward annual dividend yield 41.71%
Trailing annual dividend rate 31.84
Trailing annual dividend yield 31.69%
5-year average dividend yield 41.55
Payout ratio 442.23%
Dividend date 314 Aug 2022
Ex-dividend date 413 Jul 2022
Last split factor 210000:4798
Last split date 301 Jan 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 17.35%
Operating margin (ttm)22.58%

Management effectiveness

Return on assets (ttm)8.56%
Return on equity (ttm)22.26%

Income statement

Revenue (ttm)44.51B
Revenue per share (ttm)25.13
Quarterly revenue growth (yoy)13.80%
Gross profit (ttm)25.01B
EBITDA 13.48B
Net income avi to common (ttm)7.7B
Diluted EPS (ttm)4.31
Quarterly earnings growth (yoy)36.50%

Balance sheet

Total cash (mrq)8.16B
Total cash per share (mrq)4.66
Total debt (mrq)17.12B
Total debt/equity (mrq)48.06
Current ratio (mrq)1.85
Book value per share (mrq)20.22

Cash flow statement

Operating cash flow (ttm)9.96B
Levered free cash flow (ttm)7.54B